MCMCB Pro
G9919

G9919Screening performed and positive and provision of recommendations

HCPCSActiveBETOS Z2

G9919 is a HCPCS Level II code for screening performed and positive and provision of recommendations. It belongs to the Procedures and Professional Services (Temporary) section. Medicare does not pay it — see the coverage note below before you bill it.

Medicare coverage: Not payable by Medicare

Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusI

Not valid for Medicare purposes. Medicare uses another code.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for G9919

Long descriptor
Screening performed and positive and provision of recommendations

The official wording. This is what the code means.

Short descriptor
Scrn nd pos nd prov of rec

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2018

When CMS introduced the code.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to G9919

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G9919 is not quite right, the correct code is very often within a few positions of it.

  • G9911Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy
  • G9912Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
  • G9913Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified
  • G9914Patient initiated an anti-tnf agent
  • G9915No record of hbv results documented
  • G9916Functional status performed once in the last 12 months
  • G9917Documentation of advanced stage dementia and caregiver knowledge is limited
  • G9918Functional status not performed, reason not otherwise specified
  • G9920Screening performed and negative
  • G9921No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specifiedterminated
  • G9922Safety concerns screen provided and if positive then documented mitigation recommendations
  • G9923Safety concerns screen provided and negative
  • G9924Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)terminated
  • G9925Safety concerns screening not provided, reason not otherwise specified
  • G9926Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources
  • G9927Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatmentterminated

Questions about G9919

What is HCPCS code G9919?

G9919 is a HCPCS Level II code for screening performed and positive and provision of recommendations. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G9919?

The CMS HCPCS file marks G9919 as "Not payable by Medicare". Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.

How is G9919 paid under the physician fee schedule?

G9919 carries PFS status code I. Not valid for Medicare purposes. Medicare uses another code.

HCPCS Level II2026Q3-Jul· effective July 1, 2026